Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study

By sjmartinez • April 23, 2025

Abdollahi A, Sani MM, Shabani M, Matuck BS, Blaha MJ, Wu CO, Ambale-Venkatesh B, Budoff MJ, Strom JB, Rotter JI, Post WS, Blumenthal RS, Bluemke DA, Ghahramani N, Lima JAC, Whelton SP. Aortic valve calcium as a novel risk marker for kidney function deterioration: The MESA study. Eur J Intern Med. 2025 Apr 21:S0953-6205(25)00131-1. doi: 10.1016/j.ejim.2025.03.037. Epub ahead of print. PMID: 40263084.

Tags: albuminuria, aortic valve calcium, Cardiology/Epi, Chronic kidney disease, Harbor UCLA, Publications

Implementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy

Cho DJ, Bokhoor PI, Dermenchyan A, Brownell N, Delavin NL, Furlong S, Hoo J, Tibbe T, Chen LY, Vangala S, Waterman BA, Han M, Fonarow[...]

Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy

Juarez Casillas JE, Nikitas J, Rettig MB, Reiter RE, Lee A, Steinberg ML, Valle L, Kalbasi TR, Calais J, Czernin J, Eala MA, Tsai S,[...]

Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials

Sharifan A, Fonarow G. Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials. Heart. 2025 Jun 20:heartjnl-2025-326515. doi: 10.1136/heartjnl-2025-326515. Epub ahead of[...]